Rankings
▼
Calendar
ARCT Q2 2023 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena
ARCT
Arcturus Therapeutics Holdings Inc.
$217M
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$11M
-61.2% YoY
Gross Profit
$7M
64.4% margin
Operating Income
-$55M
-526.4% margin
Net Income
-$53M
-499.6% margin
EPS (Diluted)
$-1.98
QoQ Revenue Growth
-86.9%
Cash Flow
Operating Cash Flow
$51M
Free Cash Flow
$50M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$431M
Total Liabilities
$145M
Stockholders' Equity
$285M
Cash & Equivalents
$323M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$11M
$27M
-61.2%
Gross Profit
$7M
-$11M
+161.1%
Operating Income
-$55M
-$22M
-150.7%
Net Income
-$53M
-$22M
-143.7%
Revenue Segments
Grant
$954,000
100%
← FY 2023
All Quarters
Q3 2023 →